{"id":193485,"name":"BIOGEN","slug":"biogen","state":"DC","country":"United States of America","description":"Medical Technology Firm","totalSpending":200000,"filings":4,"yearlySpending":[{"year":2018,"income":200000}],"issues":["HCR","MMM"],"firms":["W STRATEGIES, LLC"],"lobbyists":["DARREN WILLCOX"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["FY 2017/2018 Labor/HHS appropriations bills as it relates to funding for newborn screening.  \n\nEducation about the RUSP (Recommended Uniform Screening Panel) as it relates to SMA.\n\nEducation about inn","Education about obstacles to patient access for coverage of rare disease therapies in Medicaid.","FY 2019 Labor/HHS appropriations bills as it relates to funding for newborn screening.  \n\nEducation about the RUSP (Recommended Uniform Screening Panel) as it relates to SMA.\n\nEducation about innovati","Education about obstacles to patient access for coverage of rare disease therapies in Medicaid.\n\nH.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D \"donut hole\" provision.","FY 2019 Labor/HHS appropriations bill as it relates to funding for newborn screening.  \n\nEducation about the RUSP (Recommended Uniform Screening Panel) as it relates to SMA.\n\nEducation about innovativ"],"years":[2018]}